Jiménez, A.; Estudillo, E.; Guzmán-Ruiz, M.A.; Herrera-Mundo, N.; Victoria-Acosta, G.; Cortés-Malagón, E.M.; López-Ornelas, A.
Nanotechnology to Overcome Blood–Brain Barrier Permeability and Damage in Neurodegenerative Diseases. Pharmaceutics 2025, 17, 281.
https://doi.org/10.3390/pharmaceutics17030281
AMA Style
Jiménez A, Estudillo E, Guzmán-Ruiz MA, Herrera-Mundo N, Victoria-Acosta G, Cortés-Malagón EM, López-Ornelas A.
Nanotechnology to Overcome Blood–Brain Barrier Permeability and Damage in Neurodegenerative Diseases. Pharmaceutics. 2025; 17(3):281.
https://doi.org/10.3390/pharmaceutics17030281
Chicago/Turabian Style
Jiménez, Adriana, Enrique Estudillo, Mara A. Guzmán-Ruiz, Nieves Herrera-Mundo, Georgina Victoria-Acosta, Enoc Mariano Cortés-Malagón, and Adolfo López-Ornelas.
2025. "Nanotechnology to Overcome Blood–Brain Barrier Permeability and Damage in Neurodegenerative Diseases" Pharmaceutics 17, no. 3: 281.
https://doi.org/10.3390/pharmaceutics17030281
APA Style
Jiménez, A., Estudillo, E., Guzmán-Ruiz, M. A., Herrera-Mundo, N., Victoria-Acosta, G., Cortés-Malagón, E. M., & López-Ornelas, A.
(2025). Nanotechnology to Overcome Blood–Brain Barrier Permeability and Damage in Neurodegenerative Diseases. Pharmaceutics, 17(3), 281.
https://doi.org/10.3390/pharmaceutics17030281
